Schlüter V, Meyer M, Hofschneider P H, Koshy R, Caselmann W H
Max-Planck-Institut für Biochemie, Department of Virus Research, Martinsried, Germany.
Oncogene. 1994 Nov;9(11):3335-44.
The hepatitis B virus (HBV) frequently integrates into hepatocellular genomic DNA during viral infection. Transcriptional transactivators encoded by integrated HBV X and 3' truncated preS/S sequences are known to stimulate gene expression from homologous and heterologous promoters. Here we demonstrate that 21 of 26 (81%) hepatocellular carcinoma tissues/cell lines contain coding sequences for at least one of the two known transactivators. Four integrated X and three preS/S transactivator sequences contained in five isolates from three hepatoma primary tissues or cell lines were used as examples to prove functionality of the encoded transactivators. In one case, where both X and preS/S sequences were present, dissection of X and preS/S transactivator sequences showed independent functionality. The investigation of X- and preS/S-specific RNA and protein expression revealed the existence of carboxyterminally truncated viral-cellular fusion proteins that were able to stimulate gene expression from the c-fos proto-oncogene promoter five- to ten-fold. These results demonstrate that structurally intact HBV transactivator sequences are integrated in the majority of HBV-associated HCCs/hepatoma cell lines. In all tested examples integrated DNAs had retained functionality as transactivators. This data thereby support indirectly the hypothesis of a possible involvement of HBV transactivators in liver cell proliferation and hepatocarcinogenesis.
在病毒感染期间,乙型肝炎病毒(HBV)常整合入肝细胞基因组DNA。已知由整合的HBV X及3'端截短的preS/S序列编码的转录反式激活因子可刺激同源和异源启动子的基因表达。在此我们证明,26个肝细胞癌组织/细胞系中有21个(81%)含有这两种已知反式激活因子中至少一种的编码序列。从三个肝癌原发组织或细胞系的五个分离株中所含的四个整合X及三个preS/S反式激活因子序列用作实例以证明所编码反式激活因子的功能。在一个同时存在X和preS/S序列的病例中,对X和preS/S反式激活因子序列的剖析显示其具有独立功能。对X特异性和preS/S特异性RNA及蛋白质表达的研究揭示存在能将原癌基因c-fos启动子的基因表达刺激5至10倍的羧基末端截短的病毒-细胞融合蛋白。这些结果表明,结构完整的HBV反式激活因子序列整合于大多数HBV相关的肝癌/肝癌细胞系中。在所有测试实例中,整合的DNA均保留了作为反式激活因子的功能。因此,该数据间接支持了HBV反式激活因子可能参与肝细胞增殖和肝癌发生的假说。